Oncology The Future of Chronic Lymphocytic Leukemia Management expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology Watch and Wait in Chronic Lymphocytic Leukemia: Doctor-Patient Dialogue patient care perspectives By John C. Byrd, MD
Oncology Preserving Antitumor Immune-Mediated Mechanisms of Monoclonal Antibodies clinical topic updates By John C. Byrd, MD
Oncology Intolerance to First-Generation Bruton Tyrosine Kinase Inhibition patient care perspectives By John C. Byrd, MD
Oncology Clinical Significance of Improved Bruton Tyrosine Kinase Inhibitor Selectivity clinical topic updates By John C. Byrd, MD